Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Am J Surg Pathol. 2014 May;38(5):654–659. doi: 10.1097/PAS.0000000000000195

Table 4.

Sensitivity and Specificity of single antibodies for predicting fusion status in rhabdomyosarcoma

Antibody Sensitivity Specificity
ARMS/ERMS TMA
    AP2beta 93% 94%
    HMGA2 89% 73%
    Myogenin 100% 51%
    NOS1 83% 94%
Lookback TMA
    AP2beta 91% 93%
    HMGA2 83% 80%
    Myogenin 96% 65%
    NOS1 71% 96%